Protective effect of ischaemic preconditioning on ischaemia/reper-fusion-induced microvascular obstruction determined by online measurements of coronary pressure and blood flow in pigs

Summary

We investigated the protective effect of ischaemic preconditioning (IP) on the maintenance of coronary patency using online measurements of coronary pressures and blood flow in a closed-chest reperfused acute myocardial infarction (MI) model in pigs. Catheter-based 90-min occlusion followed by 60-min reperfusion of the left anterior descending coronary artery (LAD) was performed in anesthetised pigs (MI group). IP was applied (IP group) through two cycles of 5-min occlusion and 5-min reperfusion of the LAD before MI induction. Coronary patency was determined by measurements of coronary wedge pressure, collateral fractional flow reserve (FFRcoll), collateral pressure index (CPI) and absolute coronary blood flow (CBF). Inducible and constitutive nitric oxide synthase (iNOS/cNOS) activities and expressions were determined in the myocardium. Plasma levels of myeloperoxidase (MPO, index of activated leukocytes) and mean platelet volume (MPV, index of activated platelets) were measured. IP resulted in significantly lower levels of MPO (0.52 ± 0.19 vs. 1.05 ± 0.24 U/l, p<0.001) and MPV (9.1 ± 0.6 vs. 9.6 ± 1.0 fl, p=0.04), higher FFRcoll (0.17 ± 0.05 vs. 0.04 ± 0.05, p<0.001), CPI (0.13 ± 0.05 vs. 0.02 ± 0.05, p<0.001) and CBF (70.7 ± 4.2 vs. 50.8 ± 4.8 m/min, p<0.001) post-reperfusion as compared with the MI group. IP resulted in significantly higher cNOS activity and eNOS expression. Significant negative correlation was found between MPO and measures of coronary patency (FFRcoll, CPI and CBF) and cNOS activity. Moreover, cNOS activity correlated significantly with FFRcoll, CPI and CBF. In conclusion, IP attenuates the release of MPO and platelet activation, thereby contributing to the maintenance of vessel patency at microvascular level after reperfusion of the infarct-related artery.

Keywords

Nitric oxide - ischaemia/reperfusion - collateral circulation

• References

• 1 Przyklenk K, Kloner EA. Ishcemic preconditioning: exploring the paradox. Prog Cardiovasc Dis 1998; 40: 517-547.
• 2 Yellon DM, Baxter GF, Garcia-Dorado D. et al. Ischaemic preconditioning: present position and future directions. Cardiovasc Res 1998; 37: 21-33.
• 3 Baxter GF, Yellon DM. Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?. Br J Clin Pharmacol 1994; 38: 381-387.
• 4 Papanastasious S, Estdale SE, Homer-Vanniasinkam S. et al. Protective effect of preconditioning and adenosine pre-treatment in experimental skeletal muscle reperfusion injury. Br J Surg 1999; 86: 916-922.
• 5 Wang Y, Guo Y, Zhang SX. et al. Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. J Mol Cell Cardiol 2002; 34: 5-15.
• 6 Linden MD, Whittaker P, Frelinger AL. et al. Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation. J Thromb Haemost 2006; 4: 2670-2677.
• 7 Przyklenk K, Hata K, Whittaker P. et al. Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis?. J Cardiovasc Pharmacol 2000; 35: 366-375.
• 8 Folts JD, Stamler J, Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation 1991; 83: 2122-2127.
• 9 Garcia-Dorado D, Agulló L, Lluisa Sartorio C. et al. Myocardial protection against reperfusion injury: The cGMP pathway. Thromb Haemost 2009; 101: 635-642.
• 10 Montaigne D, Marechal X, Lancel S. et al. The synthetic pentasaccharide fondaparinux prevents coronary microvascular injury and myocardial dysfunction in the ischemic heart. Thromb Haemost 2008; 100: 912-919.
• 11 Sezer M, Nisanci Y, Umman B. et al. Pressure-derived collateral flow index: a strong predictor of late left ventricular remodeling after thrombolysis for acute myocardial infarction. Coron Artery Dis 2006; 17: 139-144.
• 12 Aarnoudse W, Van’t Veer M, Pijls NH. et al. Direct volumetric blood flow measurements in coronary arteries by thermodilution. J Am Coll Cardiol 2007; 50: 2294-2304.
• 13 White FC, Carroll SM, Magnet A. et al. Coronary collateral development in swine after coronary artery occlusion. Circ Res 1992; 71: 1490-1500.
• 14 Carroll SM, White FC, Roth DM. et al. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Circulation 1993; 88: 198-207.
• 15 De Bruyne B, Bartunek J, Sys SU. et al. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995; 92: 39-46.
• 16 Pijls NH, Van Gelder B, Van der Voort P. et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92: 3183-3193.
• 17 De Bruyne B, Pijls NH, Bartunek J. et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001; 104: 157-162.
• 18 Pijls NH, van Son JA, Kirkeeide RL. et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87: 1354-1367.
• 19 Zimarino M, Ausiello A, Contegiacomo G. et al. Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. J Am Coll Cardiol 2006; 48: 59-65.
• 20 Perera D, Kanaganayagam GS, Saha M. et al. Coronary collaterals remain recruitable after percutaneous intervention. Circulation 2007; 115: 2015-2021.
• 21 Clark RA, Klebanoff SJ. Neutrophil-platelet interaction mediated by Myeloperoxidase and hydrogen peroxide. J Immunol 1980; 124: 399-405.
• 22 Okamoto E, Couse T, De Leon H. et al. Perivascular Inflammation After Balloon Angioplasty of Porcine. Coronary Arteries Circulation 2001; 104: 2228-2235.
• 23 Knowles RG, Salter M, Brooks SL. et al. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 1990; 172: 1042-1048.
• 24 Boughton-Smith NK, Evans SM, Laszlo F. et al. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993; 110: 1189-1195.
• 25 Brendan JR, Whittle FL, Steven M. et al. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Brit J Pharmacol 1995; 116: 2286-2290.
• 26 Aker S, Snabaitis AK, Konietzka I. et al. Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacinginduced heart failure in rabbits. Cardiovasc Res 2004; 63: 273-282.
• 27 Heinzel FR, Gres P, Boengler K. et al. Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in Pigs. Circulation Res 2008; 103: 1120-1127.
• 28 Penn MS. The role of leukocyte-generated oxidants in left ventricular remodelling. Am J Cardiol 2008; 101 (Suppl) 30D-33D.
• 29 Lefer AM, Campbell B, Scalia R. et al. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion : Role of selec-tins. Circulation 1998; 98: 1322-1328.
• 30 Engler RL, Schmid-Schonbein GW, Pavelec RS. et al. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983; 111: 98-111.
• 31 Takada M, Nadeau KC, Shaw GD. et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682-2690.
• 32 Mullane KM, Kramer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 4: 157-167.
• 33 Louks EB, Godin DV, Walley KR. et al. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. Can J Cardiol 2003; 19: 267-274.
• 34 Leary PJ, Rajasekaran S, Morrison RR. et al. A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation. Am J Physiol Heart Circ Physiol 2008; 294: H2775-2784.
• 35 Nishida K, Ohta Y, Ishiguro I. Contribution of NO synthases to neutrophil infiltration in the gastric mucosal lesions in rats with water immersion restraint stress. FEBS Lett 1998; 425: 243-248.
• 36 Huczek Z, Kochman J, Filipiak KJ. et al. Mean Platelet Volume on Admission Predicts Impaired Reperfusion and Long-Term Mortality in Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. J Am Coll Cardiol 2005; 46: 284-290.
• 37 Ferdinandy P, Szilvássy Z, Balogh N. et al. Nitric oxide is involved in active preconditioning in isolated working rat hearts. Ann NY Acad Sci 1996; 793: 489-493.
• 38 Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 2006; 70: 297-307.
• 39 Laszlo F, Whittle BJ, Evans SM. et al. Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol 1995; 283: 47-53.
• 40 Post H, Schulz R, Behrends M. et al. No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol 2000; 32: 725-733.
• 41 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
• 42 Yellon DM, Downey JM. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev 2003; 83: 1113-1151.
• 43 Pabla R, Curtis MJ. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart. J Mol Cell Cardiol 1996; 28: 2111-2121.
• 44 Heusch G, Schulz R. Hibernating myocardium: new answers, still more question!. Circ Res 2002; 91: 970-977.
• 45 Gelpi RJ, Morales C, Cohen MV. et al. Xanthine oxidase contributes to preconditioning`s preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol 2002; 97: 40-46.
• 46 Klem I, Kim RJ. Assessment of microvascular injury after acute myocardial infarction: importance of the area at risk. Nat Clin Pract Cardiovasc Med 2008; 5: 756-757.